Home
Anti Aging Blog
Site Search
Anti Aging - 5
Anti Aging - A
Anti Aging - B
Anti Aging - C
Anti Aging - D
Anti Aging - E
Anti Aging - F
Anti Aging - G
Anti Aging - H
Anti Aging - I
Anti Aging - J
Anti Aging - K
Anti Aging - L
Anti Aging - M
Anti Aging - N
Anti Aging - O
Anti Aging - P
Anti Aging - Q
Anti Aging - R
Anti Aging - S
Anti Aging - T
Anti Aging - V
Anti Aging - Y
Anti Aging - Z
Glossary of Terms
Pinyin
Pinyin 2
Pinyin 3
Nederlands
Nederlands 2
Nederlands 3
Français
Français 2
Français 3
Deutsch
Deutsch 2
Deutsch 3
Italiano
Italiano 2
Italiano 3
Nihongo
Nihongo 2
Nihongo 3
Hangungmal
Hangungmal 2
Hangungmal 3
Polski
Polski 2
Polski 3
Português
Português 2
Português 3
Russkiy Yazyk
Russkiy Yazyk 2
Russkiy Yazyk 3
Español
Español 2
Español 3
Svenska
Svenska 2
Svenska 3
Diets
Diets 2
Dance Studios
Dance Studios 2
Hair Removal
Vitamin Stores
Health Food Stores
Acupuncture
Health Insurance
Plastic Surgery
Advertising

[?] Subscribe To
This Site

XML RSS
Add to Google
Add to My Yahoo!
Add to My MSN
Add to Newsgator
Subscribe with Bloglines
 

Glycation Theory of Aging

Glycation theory of aging proposes that nonenzymatic reactions of glucose and sugars with amino groups of proteins and nucleic acids result in altering protein and nucleic acid structure and function.

In its essence, this is the same process that causes the well-known process of "caramelization" of sugar.

Proteins, in fact, can be damaged both by free-radicals and by glycation.

Glycation is a reaction by which reducing sugars become attached to proteins without the assistance of an enzyme.

The end result can quickly re-arrange atoms such that the 2-carbon (2nd carbon) of the glucose loses its two hydrogens, resulting in a carbonyl group structure called an Amadori product (a ketoamine).

Both glycation and Amadori product formation are completely reversible reactions.

But the formation of Advanced Glycation End-products (AGEs) by oxidation of Amadori products is irreversible.

AGEs in tissues increase the rate of free radical production to 50-times the rate of free-radical production by unglycated proteins, which has been associated with accelerated aging.

AGEs can be formed in the body from glycation and oxidation or can be ingested directly from browned foods or tobacco smoke.

According to research, about one third of absorbed dietary AGEs are excreted in urine and rest is presumably incorporated into body tissues.

In mammals, lens crystallines, collagen and basement membrane are most vulnerable to cross-linking and AGE formation because they are the most long-lived proteins, with a slow rate of turnover.

In terms of most active sugars for glycation, Galactose is 5 times more reactive than glucose, fructose is 8 times more reactive, deoxyglucose is 25 times more reactive, ribose is 100 times more reactive, and deoxyribose is 200 times more reactive.

In terms of anti aging measures from glycation process and AGE formation, it has been suggested in animal studies that there is correlation between high blood antioxidant levels and low levels of AGEs.

It has also been recognised that there are a group of enzymes involved in the suppression of glycation processes and repair of glycated proteins in physiological systems. These enzymes involved are (according to the Louis Camille Maillard Association): glyoxalase I, aldehyde reductases and dehydrogenases, Amadoriase and fructosamine-3-phosphokinase.

Currently, there is a continuing debate about the physiological significance of AGEs in food.

It is agreed that food is a rich source of AGEs but highly glycated proteins may not be digested efficiently.

Also, AGEs that are absorbed are probably mainly glycated amino acids or AGE free adducts which are excreted rapidly in the urine by subjects with normal renal function.

Glycation Theory of Aging - Studies

Maillard LC, Action des acides amines sur les sucres: formation des melanoidines par voie methodique. C.R.Acad.Sci.Ser.2 154: 66-68, 1912.

Ling AR and Malting J. J.Inst.Brewing 14: 521, 1908.

Pinkus G, Ueber die einwirkung von benzhydrazid auf glucose. Ber.Dtsch.Chem.Ges. 31: 31-37, 1898.

Neuberg C, The destruction of lactic aldehyde and methylglyoxal by animal organs. Biochem.Z. 49: 502-506, 1913.

Dakin HD and Dudley HW, An enzyme concerned with the formation of hydroxy acids from ketonic aldehydes. J.Biol.Chem. 14: 155-157, 1913.

Meyerhof O, The appearance and transformation of á-glycerophosphoric acid in the enzymic carbohydrate hydrolysis. Biochem.Z. 264: 40-71, 1933.

Embden DG, Deitricke HJ, and Kraft G, The intermediate processes in glycolysis in muscle. Klin.Wochenschr. 12: 213-215, 1933.

Racker E, Glutathione as a coenzyme in intermediary metabolism. In: Glutathione, pp. 165-183. Academic press, New York, 1954.

Amadori M. Atti Accad.Nazl.Lincei 2: 337-345, 1925.

Amadori M, The product of the condensation of glucose and p-phenetidine. Atti Reale Accad.Nazl.Lincei 9: 68-73, 1929.

Amadori M, The condensation product of glucose and p-anisidine. Atti Reale Accad.Nazl.Lincei 9: 226-230, 1929.

Kuhn R and Dansi A, A molecular rearrangement of N-glucosides. Ber. 69B: 1745-1754, 1936.

Kuhn R and Weygand F, The Amadori rearrangement. Ber. 70B: 769-772, 1937.

Hodge JE, Dehydrated foods: chemistry of browning reactions in model systems. J.Agric.Food Chem. 1: 928-943, 1953.

Anet EFLJ, Degradation of carbohydrates. I. Isolation of 3-deoxyhexosones. Australian J.Chem. 13: 396-403, 1960.

Kato H, Studies on browning reactions between sugars and amino compounds. V. Isolation and characterisation of new carbonyl compounds, 3-deoxyglucosones formed from N-glycosides and their significance for browning reaction. Bull.Agric.Chem.Soc.Japan 24: 1-12, 1960.

Szent-Gyorgyi A, Cell division and cancer. Science 149: 34-37, 1965.

Rahbar S, An abnormal hemoglobin in red cells of diabetics. Clin.Chim.Acta 22: 296-298, 1968.

Bonsignore A, Leoncini G, Siri A, and Ricci D, Kinetic behaviour of glyceraldehyde 3-phosphate conversion into methylglyoxal. Ital.J.Biochem. 22: 131-140, 1973.

Koenig RJ and Cerami A, Synthesis of hemoglobin A1c in normal and diabetic mice: potential model of basement membrane thickening. Proc.Natl.Acad.Sci.USA 72: 3687-3691, 1975.

Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, and Cerami A, A correlation of glucose regulation and Hemoglobin A1c in diabetes mellitus. New Engl.J.Med. 295: 417-420, 1976.

Gonen B, Rubenstein AH, Rochman H, Tanega SP, and Horwit DL, Haemoglobin A1: An indicator of the metabolic control of diabetic patients. Lancet ii: 734-737, 1977.

Gabbay KH, Sosenko JM, Banuchi GA, Mininsohn MJ, and Fluckiger R, Glycosylated hemoglobins: increased glycosylation of hemoglobin A in diabetic patients. Diabetes 28: 337-340, 1979.

Gonen B and Rubenstein AH, Hemoglobin A1 and diabetes mellitus. Diabetologia 15: 1, 1978.

Takahashi K, The reaction of phenylglyoxal with arginine residues in proteins. J.Biol.Chem. 6171-6179, 1968.

Takahashi K, Further studies on the reactions of phenylglyoxal and related reagents with proteins. Biochem.J. 81: 403-414, 1977.

Nakayama T, Hayase F, and Kato H, Formation of Ne-(2-formyl-5-hydroxy-methyl-pyrrol-1-yl)-L- norleucine in the Maillard reaction between D-glucose and L-lysine. Agric.Biol.Chem. 44: 1201-1202, 1980.

Hayashi T and Namiki M, Formation of two-carbon sugar fragments at an early stage of the browning reaction of sugar and amine. Agric.Biol.Chem. 44: 2575-2580, 1980.

Pongor S, Ulrich PC, Benesath FA, and Cerami A, Aging of protiens: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc.Natl.Acad.Sci.USA 81: 2684-2688, 1984.

Njoroge FG, Fernandes AA, and Monnier VM, Mechanism of the formation of the putative advanced glycosylation endproduct and protein cross-link 2-(2-furoyl)-4(5)- (2-furanyl)-1H-imidazole. J.Biol.Chem. 263: 10646-10652, 1988.

Horiuchi S, Shiga M, Araki N, Takata K, Saituh M, and Morino Y, Evidence against in vivo presence of 2-(2-furoyl)-4(5)-(2- furanyl)-1H-imidazole, a major fluorescent advanced end product generated by nonenzymatic glycosylation. J.Biol.Chem. 263: 18821-18826, 1988.

Thornalley PJ, The glyoxalase system in health and disease. Molecular Aspects of Medicine 14: 287-371, 1993.

Thornalley PJ, Wolff SP, Crabbe J, and Stern A, The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. Biochim.Biophys.Acta 797: 276-287, 1984.

Cerami A, Aging of proteins and nucleic acids: what is the role of glucose? TIBS 11: 311-314, 1986.

Brownlee M, Vlassara H, Kooney A, Ulrich P, and Cerami A, Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629-1632, 1986.

Nicholls K and Mandel TE, Advanced glycosylation endproducts in experimental murine nephropathy. Lab.Invest. 60: 486-493, 1989.

Ahmed MU, Thorpe SR, and Baynes JW, Identification of Ne-carboxymethyl-lysine as a degradation product of fructoselysine in glycated protein. J.Biol.Chem. 261: 4889-4894, 1986.

Njoroge FG, Sayre LM, and Monnier VM, Detection of D-glucose derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr.Res. 167: 211-220, 1987.

Thornalley PJ, Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem.J. 254: 751-755, 1988.

Ahmed MU, Dunn JA, Walla MD, Thorpe SR, and Baynes JW, Oxidative degradation of glucose adducts to protein. (Formation of 3-(Ne-lysino)-lactic acid from model compounds and glycated proteins. J.Biol.Chem. 263: 8816-8821, 1988.

Sell DR and Monnier VM, Structure elucidation of a senescence crosslink from human extracellular matrix. Implication of pentoses in the aging process. J.Biol.Chem. 264: 21597-21602, 1989.

Szwergold BS, Kappler F, and Brown TR, Identification of fructose-3-phosphate in the lens of diabetic rats. Science 247: 451-454, 1990.

Horiuchi T and Kurokawa T, Purification and properties of fructosylamine oxidase from Aspergillus sp. 1005. Agric.Biol.Chem. 55: 333-338, 1991.

Schmidt A-M, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, Wang F, Pan YE, Tsang TE, and Stern D, Isolation and characterization of two binding proteins for advanced glycosylation endproducts from bovine lung which are present on the endothelial cell surface. J.Biol.Chem. 267: 14987-14997, 1992.

Bucala R, Makita Z, Koschinsky T, Cerami A, and Vlassara H, Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc.Natl.Acad.Sci.USA 90: 6434-6438, 1993.

Henle T, Walter A, Haebner R, and Klostermeryer H, Detection and identification of a protein-bound imidazolone resulting from the reaction of arginine residues and methylglyoxal. Z.Lebensm.Unters.Forsch. 199: 55-58, 1994.

Lo TWC, Westwood ME, McLellan AC, Selwood T, and Thornalley PJ, Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with Na-acetylarginine, Na-acetylcysteine, Na-acetyl-lysine, and bovine serum albumin. J.Biol.Chem. 269: 32299-32305, 1994.

Westwood ME, McLellan AC, and Thornalley PJ, Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation endproduct-modified serum albumin at the advanced glycation endproduct receptor. J.Biol.Chem. 269: 32293-32298, 1994.

Vaca CE, Fang J-L, Conradi M, and Hou S-M, Development of a 32P-postlabelling technique for the analysis of 2'-deoxyguanosine-3'-monophosphate and DNA of methylglyoxal. Carcinogenesis 15: 1887-1894, 1994.

Papoulis A, Al-Abed Y, and Bucala R, Identification of N2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation endproduct. Biochemistry 34: 648-655, 1995.

Vasan S, Zhang X, Kapurniotu A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terlecky I, Bucala R, Cerami A, Egan J, and Ulrich P, An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382: 275-278, 1996.

Thornalley PJ and Minhas HS, Rapid hydrolysis and slow a,b-dicarbonyl cleavage of an agent proposed to cleave glucose-derived protein cross-links. Biochem.Pharmacol. 57: 303-307, 1999.

Thornalley PJ, Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch.Biochem.Biophys. 419: 31-40, 2003.

Sakamoto H, Mashima T, Kazaki A, Dan S, Hashimoto Y, Naito M, and Tsuruo T, Glyoxalase I is involved in resistance of human leukemia cells to antitumour agent-induced apoptosis. Blood 95: 3214-3218, 2000.

Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, and Dawnay A, Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem.J. 375: 581-592, 2003.

Thornalley PJ, The enzymatic defence against glycation in health, disease and therapeutics: a symposium to examine the concept. Biochem.Soc.Trans. 31: 1343-1348, 2003.


Disclaimer and Terms of Aging



From Glycation Theory of Aging page to Anti Aging Guide index